{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "2686349",
  "DateCompleted": {
    "Year": "1989",
    "Month": "12",
    "Day": "26"
  },
  "DateRevised": {
    "Year": "2019",
    "Month": "09",
    "Day": "03"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0001-6632",
      "JournalIssue": {
        "Volume": "39",
        "Issue": "10",
        "PubDate": {
          "Year": "1989",
          "Month": "Oct"
        }
      },
      "Title": "Acta pathologica japonica",
      "ISOAbbreviation": "Acta Pathol Jpn"
    },
    "ArticleTitle": "Immunohistochemical and immunoblot analyses of ras-p21 expression in lung carcinomas.",
    "Pagination": {
      "StartPage": "643",
      "EndPage": "647",
      "MedlinePgn": "643-7"
    },
    "Abstract": {
      "AbstractText": [
        "Immunohistochemical and immunoblot analyses were performed on 49 cases of surgically resected primary lung carcinoma to examine the expression of ras oncogene product using monoclonal antibodies to ras-p21. Two different monoclonal antibodies, NCC-RAS-001 and RAP-5 were used for immunohistochemical study. Cancer cells of 16 cases (33%) and 15 cases (31%) were strongly positive for NCC-RAS-001 and RAP-5, respectively. The staining pattern of antibodies was heterogenous among cancer cells, even in the same case. Among various histologic type of lung cancers, squamous cell carcinomas and well-differentiated adenocarcinomas had a tendency to react more intensively than other histologic types of carcinoma. Immunoblot analysis using monoclonal antibody NCC-RAS-004 revealed the presence of ras-p21 not only in cancer tissues but also in non-cancerous tissues in all cases analysed. In 13 cases (27%), cancer tissue expressed more than twice as much ras-p21 as non-cancerous tissues. Our study showed that the over-expression of ras-p21 in lung carcinomas compared with non-cancerous tissues was a relatively common phenomenon, especially in squamous cell carcinomas and adenocarcinomas."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Pathology Division, National Cancer Center Research Institute, Tokyo, Japan."
          }
        ],
        "LastName": "Koshiishi",
        "ForeName": "Y",
        "Initials": "Y"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Noguchi",
        "ForeName": "M",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Nakajima",
        "ForeName": "T",
        "Initials": "T"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Hirohashi",
        "ForeName": "S",
        "Initials": "S"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Shimosato",
        "ForeName": "Y",
        "Initials": "Y"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Hayata",
        "ForeName": "Y",
        "Initials": "Y"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Australia",
    "MedlineTA": "Acta Pathol Jpn",
    "NlmUniqueID": "0372637",
    "ISSNLinking": "0001-6632"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antibodies, Monoclonal"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Proto-Oncogene Proteins"
    },
    {
      "RegistryNumber": "EC 3.6.5.2",
      "NameOfSubstance": "HRAS protein, human"
    },
    {
      "RegistryNumber": "EC 3.6.5.2",
      "NameOfSubstance": "Proto-Oncogene Proteins p21(ras)"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "genetics"
      ],
      "DescriptorName": "Adenocarcinoma"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Antibodies, Monoclonal"
    },
    {
      "QualifierName": [
        "genetics"
      ],
      "DescriptorName": "Carcinoma, Squamous Cell"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Gene Expression"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Immunoblotting"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Immunohistochemistry"
    },
    {
      "QualifierName": [
        "genetics"
      ],
      "DescriptorName": "Lung Neoplasms"
    },
    {
      "QualifierName": [
        "analysis",
        "genetics"
      ],
      "DescriptorName": "Proto-Oncogene Proteins"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Proto-Oncogene Proteins p21(ras)"
    }
  ]
}